| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI109230 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC371875 |
| https://europepmc.org/articles/PMC371875?pdf=render | ||
| P932 | PMC publication ID | 371875 |
| P698 | PubMed publication ID | 85634 |
| P5875 | ResearchGate publication ID | 23048410 |
| P2093 | author name string | M. Kaliner | |
| L. F. Platshon | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 | ||
| A protein binding assay for adenosine 3':5'-cyclic monophosphate | Q33703192 | ||
| Radioimmunoassay Measurement of Prostaglandins E, A, and F in Human Plasma | Q34499146 | ||
| Receptors mediating some actions of histamine | Q34794929 | ||
| Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells | Q35058237 | ||
| The release of spasmogenic substances from human chopped lung tissue and its inhibition | Q35600788 | ||
| Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat | Q36268692 | ||
| Immunological release of histamine and slow reacting substance of anaphylaxis from human lung | Q36271929 | ||
| A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue | Q36272620 | ||
| Decreased H2 Histamine Response of Granulocytes of Asthmatic Patients | Q37044830 | ||
| Human lung tissue and anaphylaxis. Evidence that cyclic nucleotides modulate the immunologic release of mediators through effects on microtubular assembly | Q37047778 | ||
| Classification and biological distribution of histamine receptor sub-types | Q39071854 | ||
| Neurohumoral interactions in airways | Q39150089 | ||
| On the structure of slow reacting substance of anaphylaxis: Evidence of biosynthesis from arachidonic acid | Q39162123 | ||
| Histamine (second of two parts). | Q39363739 | ||
| Release of prostaglandins and histamine from sensitized and anaphylactic guinea pig lungs—changes in cyclic AMP levels | Q39426594 | ||
| Release of Histamine and Formation of Prostaglandins in Human Lung Tissue and Rat Mast Cells | Q39436711 | ||
| Further Studies on Passive Peritoneal Anaphylaxis in the Rat | Q39444799 | ||
| Human lung tissue and anaphylaxis. I. The role of cyclic GMP as a modulator of the immunologically induced secretory process | Q39449330 | ||
| The relationship between prostaglandin release and lung c-AMP levels during anaphylaxis in the guinea-pig | Q39965138 | ||
| Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease | Q40340276 | ||
| Release of prostaglandins from healthy and sensitized guinea-pig lung and trachea by histamine | Q41077689 | ||
| Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig | Q41825377 | ||
| Release of prostaglandins, a prostaglandin metabolite, slow-reacting substance and histamine from anaphylactic lungs, and its modification by catecholamines | Q43622798 | ||
| Sensitivity to intravenous injections of histamine and serotonin in inbred mouse strains. | Q45111187 | ||
| Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine | Q46146409 | ||
| Effect of anaphylaxis and histamine, pyrilamine and burimamide on levels of cyclic AMP and cyclic GMP in guinea-pig lung. | Q46340493 | ||
| Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs | Q46576516 | ||
| Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents | Q46699453 | ||
| Definition and antagonism of histamine H 2 -receptors | Q46704110 | ||
| Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine | Q46796466 | ||
| Inhibition of histamine release by histamine controlled by H2 receptor. | Q52728985 | ||
| Effect of a histamine H-2-receptor antagonist on immunologically induced mediator release in vitro. | Q53785078 | ||
| Probable role of prostaglandins in asthma | Q54002553 | ||
| Modulation of the release of SRS-A from bovine lung in vitro by several autonomic and autacoid agents | Q67451351 | ||
| In vitro anaphylaxis in guinea-pig skin: amplification by burimamide | Q68214264 | ||
| Radioimmunoassay for the measurement of cyclic nucleotides | Q68663986 | ||
| Radioimmunoassay for Prostaglandins | Q71747125 | ||
| Histamine augments leukocyte adenosine 3',5'-monophosphate and blocks antigenic histamine release | Q93708055 | ||
| Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP | Q93713479 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1113-1121 | |
| P577 | publication date | 1978-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation | |
| The Effects of the Immunologic Release of Histamine upon Human Lung Cyclic Nucleotide Levels and Prostaglandin Generation | |||
| P478 | volume | 62 |
| Q42461353 | Airway epithelium: more than just a barrier! |
| Q39672294 | Airway smooth muscle and disease workshop: histamine and prostanoids |
| Q46217898 | Allergen tachyphylaxis of guinea pigs in vivo; a prostaglandin E mediated phenomenon? |
| Q72590891 | Anaphylaxis: Pathophysiology, clinical presentations and treatment |
| Q36261174 | Assessment of bronchodilatation after spontaneous recovery from a histamine challenge in asthmatic children |
| Q69101967 | Azelastine inhibits stimulated histamine release from human lung tissue in vitro but does not alter cyclic nucleotide content |
| Q44567287 | Bronchial hyper-reactivity in atopic patients during H2-receptor blocker treatment. |
| Q36004404 | Changes in bronchial anaphylactic reactivity induced in guinea-pigs by long-term treatment with histamine H2-agents |
| Q36498020 | Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5'-monophosphate challenge in asthma |
| Q40104831 | Control of mediator release from mast cells |
| Q43917428 | Decreased antigen-induced eicosanoid release in conjugated linoleic acid-fed guinea pigs |
| Q36633985 | Diphenhydramine blocks the leukotriene-C4 enhanced mucus secretion in canine trachea in vivo |
| Q41129464 | Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man. |
| Q24601699 | Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro |
| Q39565312 | Ethanol inhibition of antigen-induced histamine release from guinea pig lung: Correlation with intracellular levels of cyclic nucleotides |
| Q42149571 | Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man. |
| Q35552822 | H1-receptors: localization and role in airway physiology and in immune functions |
| Q44788534 | Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. |
| Q40109734 | Histamine |
| Q71227044 | Histamine H-1 binding site on human polymorphonuclear leukocytes |
| Q50802569 | Histamine H1-receptor-mediated cyclic GMP production in guinea-pig lung tissue is an l-arginine-dependent process |
| Q34628308 | Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors |
| Q51829569 | Histamine-induced middle ear effusion and mucosal histopathology in the guinea pig. |
| Q53937154 | Histamine1--histamine2 antagonism: effect of combined clemastine and cimetidine pretreatment on allergen and histamine-induced reactions of the guinea pig lung in vivo and in vitro. |
| Q28366267 | Human airway monohydroxyeicosatetraenoic acid generation and mucus release |
| Q46916688 | Immune-related intestinal Cl- secretion. I. Effect of histamine on the T84 cell line |
| Q37026884 | Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro |
| Q51633481 | Local prophylactic benadryl injections in an attempt to reduce postinstrumental pain. |
| Q41529604 | Localization of cAMP in dog and cat trachea: effects of beta-adrenergic agonists |
| Q39399589 | Mast cells in allergic diseases and mastocytosis |
| Q70154462 | Pathogenesis of Asthma: A Review |
| Q36618333 | Perioperative uses of histamine antagonists |
| Q54316063 | Pharmacological characterization of mediators and vagal influence in the acute allergic bronchoconstriction in guinea pigs. |
| Q28369003 | Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells |
| Q36477993 | Plasma cyclic nucleotide levels in exercise-induced asthma |
| Q70219522 | Preparation of a human lung purified plasma membrane fraction: Confirmation by enzyme markers, electron microscopy, and histamine H1 receptor binding |
| Q72529748 | Properties of histamine-induced suppressor factor in the regulation of lymphocyte response to PHA in mice |
| Q46560687 | Prostaglandin generation by human and guinea pig lung tissue: Comparison of parenchymal and airway responses |
| Q72395046 | Prostaglandin-generating factor of anaphylaxis induces mucous glycoprotein release and the formation of lipoxygenase products of arachidonate from human airways |
| Q46270558 | Prostaglandin-generating factor of anaphylaxis. Identification and isolation |
| Q46784153 | Radiation-induced changes in production of prostaglandins F2 alpha, E, and thromboxane B2 in guinea pig parenchymal lung tissues |
| Q34622665 | Ranitidine does not potentiate mediator release from human lung in vitro |
| Q43409180 | Resident mast cells are the main initiators of anaphylactic leukotriene production in the liver |
| Q40212548 | The human lung mast cell |
| Q72706863 | The in vitro synthesis and degradation of prostaglandins during the development of bleomycin-induced pulmonary fibrosis in hamsters1−3 |
| Q35035232 | The lung mast cell: its physiology and potential relevance to defense of the lung |
| Q68444563 | The role of H2-receptors in bronchial reactivity in atopic asthma |
| Q40103788 | Treatment of Urticaria |
| Q36977334 | Tryptase activates calcium-independent phospholipase A2 and releases PGE2 in airway epithelial cells |